World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
26843
World Ranking
2093
National Ranking
1021

Nancy J. Sullivan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nancy J. Sullivan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 134 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nancy J. Sullivan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy J. Sullivan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2007 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Nancy J. Sullivan is affiliated with the National Institutes of Health in the United States. Their research primarily spans the field of Medicine, with significant contributions to Infectious Diseases, Molecular Biology, and Epidemiology. Additional subfields include Animal Science and Zoology as well as Immunology.

Their main research topics focus on SARS-CoV-2 and COVID-19, with extensive work in Viral Infections and Outbreaks Research, COVID-19 Clinical Research Studies, and viral infections involving vectors and animals. Immunotherapy and immune response mechanisms also feature prominently in their portfolio.

Frequent publication venues for this researcher include bioRxiv (Cold Spring Harbor Laboratory), Science, Science Translational Medicine, New England Journal of Medicine, and Cell Reports.

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters, 2022, Nature
  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine, 2021, New England Journal of Medicine
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports
  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates, 2021, Science

The scientist has collaborated frequently with John R. Mascola, Lingshu Wang, Juan I. Moliva, Barney S. Graham, and Peter D. Kwong, indicating sustained coauthorship in multiple projects.

Nancy J. Sullivan has been recognized as a Fellow of the John Simon Guggenheim Memorial Foundation, an award received in 2007.

Best Publications

  • The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates

    Hyeryun Choe;Michael Farzan;Ying Sun;Nancy Sullivan

  • Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.

    A Trkola;M Purtscher;T Muster;C Ballaun

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

    Kartik Chandran;Nancy J. Sullivan;Ute Felbor;Sean P. Whelan

  • CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

    Lijun Wu;William A. Paxton;Nasim Kassam;Nancy Ruffing

  • Development of a preventive vaccine for Ebola virus infection in primates

    Nancy J. Sullivan;Anthony Sanchez;Pierre E. Rollin;Zhi Yong Yang

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Unknown

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

    Zhi Yong Yang;Henricus J. Duckers;Nancy J. Sullivan;Anthony Sanchez

  • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

    Jason A. Regules;John H. Beigel;Kristopher M. Paolino;Jocelyn Voell

  • Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

    N. Sullivan;Ying Sun;J. Li;W. Hofmann

  • Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

    Davide Corti;John Misasi;Sabue Mulangu;Daphne A. Stanley

  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.

    Kai Wu;Anne P Werner;Matthew Koch;Angela Choi

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection

    Michael Farzan;Hyeryun Choe;Kathleen Martin;Luisa Marcon

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Unknown

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

    Wendelien B Oswald;Thomas W Geisbert;Kelly J Davis;Joan B Geisbert

  • A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

    Julie E Martin;Nancy J Sullivan;Mary E Enama;Ingelise J Gordon

  • Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Nancy J. Sullivan;Julie E. Martin;Barney S. Graham;Gary J. Nabel

  • Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

    Nancy J Sullivan;Thomas W Geisbert;Joan B Geisbert;Devon J Shedlock

Frequent Co-Authors

Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
John R. Mascola
John R. Mascola ModeX Therapeutics
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open diverse career opportunities in healthcare. Programs like the cheapest online pmhnp programs offer affordable pathways into specialized nursing roles that complement immunology knowledge.

Nurse practitioners with advanced degrees often enjoy competitive salaries. Understanding how much do dnps make can help prospective students evaluate the return on investment for their education and career planning.

Many clinicians start as family nurse practitioners and then specialize. Learning about the transition process, such as the steps involved in fnp to acnp, is vital for those aiming to focus on acute care settings where immunology-related expertise is crucial.

For accelerated entry, accelerated np programs provide a fast-track option to advanced practice roles, catering to students with prior healthcare experience seeking to advance efficiently.

Best Scientists Citing Nancy J. Sullivan

Trending Scientists